Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (7): 120-124.doi: 10.6040/j.issn.1671-7554.0.2024.0232
• 病例报道 • Previous Articles
CLC Number:
| [1] Wu F, Xia CW, Hai R, et al. Papillary thyroid carcinoma with clear cell renal cell carcinoma metastasized to the thyroid gland: a case report[J]. Oncol Lett, 2023, 26(6): 528. [2] Cheville JC, Lohse CM, Zincke H, et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma[J]. Am J Surg Pathol, 2003, 27(5): 612-624. [3] Miah MS, White SJ, Oommen G, et al. Late simultaneous metastasis of renal cell carcinoma to the submandibular and thyroid glands seven years after radical nephrectomy[J]. Int J Otolaryngol, 2010, 2010: 698014. doi:10.1155/2010/698014. [4] Moudouni SM, Tligui M, Doublet JD, et al. Late metastasis of renal cell carcinoma to the submaxillary gland 10 years after radical nephrectomy[J]. Int J Urol, 2006, 13(4): 431-432. [5] Balaban M, Dogruyol SV, Idilman IS, et al. Renal cell carcinoma metastasis to ipsilateral parotid and submandibular glands: report of a case with sonoelastographic findings[J]. Pol J Radiol, 2016, 81: 17-20. doi:10.12659/PJR.895430. [6] Serouya SM, Dultz LA, Concors SJ, et al. Late solitary metastasis of renal cell carcinoma to the submandibular gland[J]. J Oral Maxillofac Surg, 2012, 70(10): 2356-2359. [7] Majewska H, Skálová A, Radecka K, et al. Renal clear cell carcinoma metastasis to salivary glands - a series of 9 cases: clinico-pathological study[J]. Pol J Pathol, 2016, 67(1): 39-45. [8] Ficarra G, Pierleoni L, Panzoni E. Metastatic renal cell carcinoma involving Wharton’s duct: a case report[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 1996, 81(5): 580-583. [9] Barnes, Leon, Eveson, et al. WHO organization classification of tumors. Pathology and genetics of head and neck tumors[M]. 3th ed. Lyon: IARC Press, 2005: 430. [10] 周嫔, 叶恩如, 杨佩浓, 等. 肾透明细胞癌术后10年转移至颌下腺1例[J]. 浙江医学, 2020, 42(24): 2693-2694. ZHOU Pin, YE Enru, YANG Peinong, et al. Metastasis of renal clear cell carcinoma to submandibular gland 10 years after operation: a case report[J]. Zhejiang Medical Journal, 2020, 42(24): 2693-2694. [11] Smits JG, Slootweg PJ. Renal cell carcinoma with metastasis to the submandibular and parotid glands. A case report[J]. J Maxillofac Surg, 1984, 12(5): 235-236. [12] Bedrosian SA, Goldman RL, Dekelboum AM. Renal carcinoma presenting as a primary submandibular gland tumor[J]. Oral Surg Oral Med Oral Pathol, 1984, 58(6): 699-701. [13] Higuera F, Boccalatte LA, Labanca J, et al. Renal clear cell carcinoma metastasis to submandibular gland: case report and review of the literature[J]. J Surg Case Rep, 2018(10):261. [14] Liu F, Li FY, Zhou RX. Unusual case of gallstones with chronic cholecystitis revealing a metachronous gallbladder metastasis from renal clear cell carcinoma[J]. ANZ J Surg, 2020, 90(4): E87-E88. [15] Udager AM, Rungta SA. Metastatic renal cell carcinoma, clear cell type, of the parotid gland: a case report, review of literature, and proposed algorithmic approach to salivary gland clear cell neoplasms in fine-needle aspiration biopsies[J]. Diagn Cytopathol, 2014, 42(11): 974-983. [16] 张凯, 朱刚. 2020版EAU肾细胞癌诊疗指南更新解读之二[J]. 中华泌尿外科杂志, 2020, 41(8): 578-580. ZHANG Kai, ZHU Gang. The update interpretation of 2020 EAU renal cell carcinoma guideline(Part Ⅱ)[J]. Chinese Journal of Urology, 2020, 41(8): 578-580. [17] Albiges L, Tannir NM, Burotto M, et al. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial[J]. ESMO Open, 2020, 5(6): e001079. [18] Rini BI, Plimack ER, Stus V, et al. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma[J]. N Engl J Med, 2019, 380(12): 1116-1127. [19] Motzer RJ, Tannir NM, McDermott DF, et al. Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma[J]. N Engl J Med, 2018, 378(14): 1277-1290. [20] Choueiri TK, Hessel C, Halabi S, et al. Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk(Alliance A031203 CABOSUN randomised trial): progression-free survival by independent review and overall survival update[J]. Eur J Cancer, 2018, 94: 115-125. doi:10.1016/j.ejca.2018.02.012. [21] Powles T, Motzer RJ, Albiges L, et al. Outcomes by IMDC risk in the COSMIC-313 phase 3 trial evaluating cabozantinib(C)plus nivolumab(N)and ipilimumab(I)in first-line advanced RCC(aRCC)of IMDC intermediate or poor risk[J]. J Clin Oncol, 2023, 41(6_suppl): 605. |
| [1] | LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51. |
| [2] | GAO Pei, MAO Changlin, CHEN Feng, HE Wei, GUAN Yong,LYU Jiaju, LI Shanjun, DING Sentai. Application of CT three-dimensional reconstruction modified R.E.N.A.L. score in 50 cases of laparoscopic partial nephrectomy [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 52-57. |
| [3] | ZHAO Zuohui, LI Cuiling, WANG Daoguang, WANG Fengqin, QU Hongyi, DING Sentai, GONG Jing, LÜ Jiaju, YANG Jinghua. Effect of MnSOD acetylation on the proliferation and apoptosis of clear cell renal cell carcinoma cell line 786-O [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 31-35. |
| [4] | SU Jing, XUE Jiaomei, SUN Feifei, GUO Zhaoxin, CHENG Xiangyu, MENG Liwei, LIU Zhaoxu. Comparison of nephron-sparing surgery and radical nephrectomy for T1b renal cell carcinoma: a Meta-analysis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(9): 65-70. |
| [5] | XIE Fang, LIU Shuai, LIU Zheng, NIU Zhi-hong. NOV modulates expression of Ki-67,VEGF，p27 and COX-2 in renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(10): 29-32. |
| [6] | ZHANG Bin1, CHEN Jie2, LIU Yan3, ZHANG Shi-bao2, LIU Shuang-qing2, LIU Bo2,WANG Quan-ying4, YANG Guang-xiao4, LIU Qing-yong2. Anti-tumor effect of recombinant adeno-associated virus mediated secretive expression of renal cell carcinoma suppressor fusion peptide on chick embryo implanted tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 33-36. |
| [7] | XIONG Hui1, XIA Ting2， JIANG Shaobo1, XIA Qinghua1, ZHAO Yong1, JIN Xunbo1. Effect of the renal volume on surgical occasion for patients with autosomal dominant polycystic kidney disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(8): 96-99. |
| [8] | TIAN Su-jian1, CHENG Li2, XU Zhong-hua1, REN Ju-chao1, LI Da-wei1, LIU Hai-nan1. Relationship of renal cell carcinoma angiogenesis with heparanase and cyclooxygenase-2 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 135-139. |
| [9] | Lv Yi-jing, REN Min, WANG Bo, GE Ru-qing, ZHANG Ji-dong. Expressions of CTGF and EZH2 in renal clear cell carcinoma and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 85-89. |
| [10] | LIU Hai-nan1,2, LI Da-wei2, ZHANG Jian-ping3, REN Ju-chao2, TIAN Su-jian2, FANG Zhi-qing2, L Jia-ju1. Expression and clinical significance of HepaCAM expression in renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 81-84. |
| [11] | Lv Yi-jing, REN Min, WANG Bo, GE Ru-qing, ZHANG Ji-dong. Expressions of CTGF and EZH2 in renal clear cell carcinoma and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 85-89. |
| [12] | LIU Hai-nan1,2, LI Da-wei2, ZHANG Jian-ping3, REN Ju-chao2, TIAN Su-jian2, FANG Zhi-qing2, L Jia-ju1. Expression and clinical significance of HepaCAM expression in renal clear cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(3): 81-84. |
| [13] | CHEN Qiang1,2, L Jiaju1, JING Tao2, LI Yujun3. Expressions of MMP-2/ CXCR4 and their clinical significance in renal clear cell carcinoma tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(6): 107-. |
| [14] | HAN Letian, DING Kejia. Expression and significance of cyclin D1, cyclin E and p27 in transitional cell carcinoma of the renal pelvis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 109-112. |
| [15] | LI Caixia, XIE Fubo, ZHANG Kai. TACE for patients with renal carcinoma and the influence on cell immune function [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(2): 121-123. |
|
